Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma
Completed · Phase 2
Conditions studied: Sarcoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of high-dose combination chemotherapy and peripheral stem cell transplantation in treating patients who have advanced or recurrent sarcoma.
Key facts
- Study ID
- NCT00002601
- Run by
- City of Hope Medical Center
- People needed
- 13
- Starts
- 1994-09-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2017-03-03
Who can join
Age: 10 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Center and Beckman Research Institute, City of Hope — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.